Related Experiment Video
Updated: Mar 30, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC
Zi Wang1,2, Bianyin Ma1, Hui Li1
1The State Key Laboratory of Medical Genetics and School of Life Sciences, Central South University, Changsha, China.
Abstract:
Protein 4.1N is a member of protein 4.1 family and has been recognized as a potential tumor suppressor in solid tumors. Here, we aimed to investigate the role and mechanisms of 4.1N in non-small cell lung cancer (NSCLC). We confirmed that the expression level of 4.1N was inversely correlated with the metastatic properties of NSCLC cell lines and histological grade of clinical NSCLC tissues. Specific knockdown of 4.1N promoted tumor cell proliferation, migration and adhesion in vitro, and tumor growth and metastasis in mouse xenograft models. Furthermore, we identified PP1 as a novel 4.1N-interacting molecule, and the FERM domain of 4.1N mediated the interaction between 4.1N and PP1. Further, ectopic expression of 4.1N could inactivate JNK-c-Jun signaling pathway through enhancing PP1 activity and interaction between PP1 and p-JNK. Correspondingly, expression of potential downstream metastasis targets (ezrin and MMP9) and cell cycle targets (p53, p21 and p19) of JNK-c-Jun pathway were also regulated by 4.1N. Our data suggest that down-regulation of 4.1N expression is a critical step for NSCLC development and that repression of JNK-c-Jun signaling through PP1 is one of the key anti-tumor mechanisms of 4.1N.
Insights
Protein 4.1N acts as a tumor suppressor in non-small cell lung cancer (NSCLC). Its reduced expression promotes tumor growth and metastasis by activating the JNK-c-Jun pathway via PP1, highlighting 4.1N as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Protein 4.1N is a known tumor suppressor in solid tumors.
- Its specific role and mechanisms in non-small cell lung cancer (NSCLC) require further investigation.
Purpose of the Study:
- To investigate the function and underlying mechanisms of Protein 4.1N in NSCLC.
- To determine the correlation between 4.1N expression and NSCLC progression.
- To identify molecular interactions and signaling pathways regulated by 4.1N.
Main Methods:
- Correlation analysis of 4.1N expression with NSCLC cell line metastatic properties and clinical tissue grades.
- In vitro studies involving knockdown of 4.1N to assess effects on cell proliferation, migration, and adhesion.
- In vivo studies using mouse xenograft models to evaluate tumor growth and metastasis.
- Identification of 4.1N-interacting molecules using biochemical assays.
- Analysis of signaling pathways, including JNK-c-Jun, and their downstream targets.
Main Results:
- 4.1N expression inversely correlates with NSCLC metastatic potential and tumor grade.
- Knockdown of 4.1N enhances NSCLC cell proliferation, migration, adhesion, tumor growth, and metastasis.
- Protein phosphatase 1 (PP1) identified as a novel interacting molecule, with the FERM domain of 4.1N mediating this interaction.
- Ectopic expression of 4.1N inactivates the JNK-c-Jun pathway by enhancing PP1 activity and its interaction with p-JNK.
- 4.1N regulates downstream targets of the JNK-c-Jun pathway, including ezrin, MMP9, p53, p21, and p19.
Conclusions:
- Down-regulation of 4.1N is a critical factor in NSCLC development.
- 4.1N exerts anti-tumor effects by repressing the JNK-c-Jun signaling pathway through PP1.
- Targeting 4.1N or its associated pathway presents a potential therapeutic strategy for NSCLC.
More Related Videos
08:37Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions